CN116288203A - Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof - Google Patents
Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof Download PDFInfo
- Publication number
- CN116288203A CN116288203A CN202310231767.4A CN202310231767A CN116288203A CN 116288203 A CN116288203 A CN 116288203A CN 202310231767 A CN202310231767 A CN 202310231767A CN 116288203 A CN116288203 A CN 116288203A
- Authority
- CN
- China
- Prior art keywords
- composite coating
- zno
- cuo
- sputtering
- corrosion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 138
- 239000002131 composite material Substances 0.000 title claims abstract description 136
- 239000011248 coating agent Substances 0.000 title claims abstract description 130
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 64
- 238000005260 corrosion Methods 0.000 title claims abstract description 53
- 230000007797 corrosion Effects 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000010410 layer Substances 0.000 claims abstract description 74
- 239000000758 substrate Substances 0.000 claims abstract description 50
- 239000002344 surface layer Substances 0.000 claims abstract description 45
- 230000007704 transition Effects 0.000 claims abstract description 45
- 229910052751 metal Inorganic materials 0.000 claims abstract description 36
- 239000002184 metal Substances 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 34
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 claims abstract description 4
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000004544 sputter deposition Methods 0.000 claims description 51
- 238000001755 magnetron sputter deposition Methods 0.000 claims description 47
- 238000000137 annealing Methods 0.000 claims description 33
- 229910052760 oxygen Inorganic materials 0.000 claims description 23
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 22
- 239000010936 titanium Substances 0.000 claims description 22
- 229910052719 titanium Inorganic materials 0.000 claims description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 239000013078 crystal Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 15
- 229910052802 copper Inorganic materials 0.000 claims description 14
- 229910052725 zinc Inorganic materials 0.000 claims description 14
- 238000005477 sputtering target Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 10
- 230000001681 protective effect Effects 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 8
- 239000011521 glass Substances 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000007943 implant Substances 0.000 abstract description 15
- 229910044991 metal oxide Inorganic materials 0.000 abstract description 12
- 150000004706 metal oxides Chemical class 0.000 abstract description 12
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 6
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 230000009977 dual effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 238000000338 in vitro Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 244000000010 microbial pathogen Species 0.000 abstract description 2
- 230000003746 surface roughness Effects 0.000 abstract description 2
- 239000012620 biological material Substances 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 30
- 239000000203 mixture Substances 0.000 description 13
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000005317 bioglass 45S5 Substances 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 230000001699 photocatalysis Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000005312 bioglass Substances 0.000 description 4
- 238000000103 photoluminescence spectrum Methods 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000000985 reflectance spectrum Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910000838 Al alloy Inorganic materials 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- UQZIWOQVLUASCR-UHFFFAOYSA-N alumane;titanium Chemical compound [AlH3].[Ti] UQZIWOQVLUASCR-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000009916 joint effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000002159 nanocrystal Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000012431 wafers Nutrition 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000004630 atomic force microscopy Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- -1 surface nano-grains Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
- C23C14/34—Sputtering
- C23C14/35—Sputtering by application of a magnetic field, e.g. magnetron sputtering
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/06—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
- C23C14/08—Oxides
- C23C14/086—Oxides of zinc, germanium, cadmium, indium, tin, thallium or bismuth
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/06—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
- C23C14/08—Oxides
- C23C14/087—Oxides of copper or solid solutions thereof
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/58—After-treatment
- C23C14/5806—Thermal treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Physical Vapour Deposition (AREA)
Abstract
本发明公开了一种耐腐蚀、抗菌生物医用复合涂层及其制备方法,属于生物材料技术领域。所述涂层材料由ZnO、CuO和Cu2O组成,包括厚度为50nm~100nm的ZnO过渡层和厚度为150nm~500nm的ZnO、CuO和Cu2O混合而成的表层。该复合涂层金属氧化物性质稳定、结构致密,具有较好的耐腐蚀性,能有效保护基底;针刺状凸起增大了表面粗糙度,赋予涂层更好的表面亲水性;同时ZnO、CuO和Cu2O组成的表层在协同抗菌增强效应下能有效杀灭金黄色葡萄球菌、大肠杆菌等致病性微生物,表现出良好的抗菌性。复合涂层满足体内体外对耐腐蚀性和抗菌性的双重需求,适合作为功能性涂层应用于金属植入体、手术器械等生物医用材料表面。
The invention discloses a corrosion-resistant and antibacterial biomedical composite coating and a preparation method thereof, belonging to the technical field of biological materials. The coating material is composed of ZnO, CuO and Cu2O , including a ZnO transition layer with a thickness of 50nm-100nm and a surface layer mixed with ZnO, CuO and Cu2O with a thickness of 150nm-500nm. The composite coating metal oxide has stable properties, compact structure, good corrosion resistance, and can effectively protect the substrate; the needle-like protrusions increase the surface roughness and endow the coating with better surface hydrophilicity; at the same time The surface layer composed of ZnO, CuO and Cu 2 O can effectively kill pathogenic microorganisms such as Staphylococcus aureus and Escherichia coli under the synergistic antibacterial enhancement effect, showing good antibacterial properties. The composite coating meets the dual requirements of corrosion resistance and antibacterial properties in vivo and in vitro, and is suitable as a functional coating for the surface of biomedical materials such as metal implants and surgical instruments.
Description
技术领域technical field
本发明属于生物医用功能性涂层技术领域,具体涉及到一种耐腐蚀、抗菌生物医用复合涂层及其制备方法。The invention belongs to the technical field of biomedical functional coatings, and in particular relates to a corrosion-resistant and antibacterial biomedical composite coating and a preparation method thereof.
背景技术Background technique
金属植入体、手术器械等生物医用材料在临床实际应用时,因自身的金属键暴露出不耐人体体液腐蚀,容易分解失效造成植入物服役时间短;以及缺乏抗菌抑菌活性在植入后容易引发菌性感染及炎症进而导致植入手术失败等问题。为解决这些问题,研究人员尝试通过接枝、沉积、喷涂、机械共混等改性手段将活性官能团、金属与医用植入材料复合来赋予其耐腐蚀性能和抗菌性能。而经实践检验发现,上述技术手段存在改性材料在表面分布不均匀、局部耐腐蚀能力差、甚至影响基体材料原有的高强度及生物相容性等缺点,且所选改性材料也表现出抗菌活性低、长效抗菌能力弱等不足,更为严重的是,上述针对植入材料的改性研究很难同时获得较好的耐腐蚀性和抗菌性。When biomedical materials such as metal implants and surgical instruments are used in clinical practice, because their metal bonds are exposed, they are not resistant to corrosion by human body fluids, and they are easy to decompose and fail, resulting in a short service life of the implants; and the lack of antibacterial and antibacterial activities. Afterwards, it is easy to cause bacterial infection and inflammation, which will lead to problems such as failure of implantation surgery. In order to solve these problems, researchers have tried to combine active functional groups, metals and medical implant materials through grafting, deposition, spraying, mechanical blending and other modification methods to endow them with corrosion resistance and antibacterial properties. However, it has been found through practice that the above-mentioned technical means have shortcomings such as uneven distribution of modified materials on the surface, poor local corrosion resistance, and even affect the original high strength and biocompatibility of the matrix material, and the selected modified materials also exhibit However, there are some deficiencies such as low antibacterial activity and weak long-term antibacterial ability. What's more serious is that it is difficult to obtain better corrosion resistance and antibacterial property at the same time in the above research on the modification of implant materials.
针对前面研究所遗留下的缺陷,本发明经调研发现,磁控溅射技术具有操作过程简单、产量高、产品成分可控等优点,特别是经其制备的涂层是直接涂覆于基体材料表面,且厚度可控制在几百纳米以下,可以做到基本不影响基体材料的固有性质;同时磁控溅射得到的晶粒为纳米晶,在沉积时能够紧密堆垛,后续退火生长时能够进一步转变为致密结构,从而有效屏蔽基材与外界的直接接触。另一方面,磁控溅射产生的纳米晶能够刺破致病性细菌的细胞壁,对涂层的抗菌表现也有正面的积极作用。由此看来,采用磁控溅射制备功能性涂层是提升植入材料耐腐蚀性和抗菌性并同时避免其他负面影响的最佳技术手段。Aiming at the defects left over from the previous research, the present invention has found through investigation that the magnetron sputtering technology has the advantages of simple operation process, high output, controllable product composition, etc., especially the coating prepared by it is directly coated on the base material surface, and the thickness can be controlled below a few hundred nanometers, which can basically not affect the inherent properties of the matrix material; at the same time, the crystal grains obtained by magnetron sputtering are nanocrystalline, which can be tightly stacked during deposition, and can be grown during subsequent annealing. It is further transformed into a dense structure, thereby effectively shielding the direct contact between the substrate and the outside world. On the other hand, the nanocrystals produced by magnetron sputtering can pierce the cell wall of pathogenic bacteria, which also has a positive effect on the antibacterial performance of the coating. From this point of view, the preparation of functional coatings by magnetron sputtering is the best technical means to improve the corrosion resistance and antibacterial properties of implant materials while avoiding other negative effects.
在改性材料选择上,以往的活性官能团容易因表面磨损而损耗,金属耐磨性虽高,但其抗水化能力弱,过快的分解除了影响其涂层的耐腐蚀能力,更严重的是造成涂层长效抗菌能力弱,甚至因释放量过大而产生细胞毒性。而金属氧化物一方面继承了金属依靠其释放离子实现抗菌的抗菌性,另一方面借助金属原子与氧原子间的极性离子共价键来抵御水化,增加自身的耐腐蚀能力。但也是由于金属氧化物的稳定,其仅依靠释放的金属离子很难获得优异的抗菌性,所以必须从杀菌机理上寻找更理想的抗菌金属氧化物材料。其中,ZnO、CuO以及Cu2O除了具有上述金属氧化物的优势外,还是典型的n型(ZnO)和p型(CuO、Cu2O)半导体材料,可通过构建p-n结构提高光催化活性,进而在可见光范围制造更多“活性氧”物质,利用“活性氧”氧化辅酶A并干扰其基因表达来进一步杀灭细菌,从而在维持其化学性质稳定带来的耐腐蚀性的同时提升其抗菌性能。In the selection of modified materials, the active functional groups in the past are easy to be lost due to surface wear. Although the metal wear resistance is high, its hydration resistance is weak. Too fast decomposition not only affects the corrosion resistance of the coating, but also affects the corrosion resistance of the coating. It is that the long-term antibacterial ability of the coating is weak, and even cytotoxicity is produced due to excessive release. On the one hand, metal oxides inherit the antibacterial properties of metals by releasing ions, and on the other hand, they use the polar ion covalent bonds between metal atoms and oxygen atoms to resist hydration and increase their own corrosion resistance. However, due to the stability of metal oxides, it is difficult to obtain excellent antibacterial properties only by releasing metal ions, so it is necessary to find more ideal antibacterial metal oxide materials from the perspective of bactericidal mechanism. Among them, ZnO, CuO and Cu 2 O not only have the advantages of the above-mentioned metal oxides, but also are typical n-type (ZnO) and p-type (CuO, Cu 2 O) semiconductor materials, which can improve the photocatalytic activity by constructing a pn structure. Further, more "active oxygen" substances are produced in the visible light range, and the "active oxygen" is used to oxidize coenzyme A and interfere with its gene expression to further kill bacteria, thereby maintaining its chemical stability and corrosion resistance while improving its antibacterial properties performance.
本发明采用磁控溅射结合后续退火来制备一种耐腐蚀、抗菌复合涂层;该复合涂层具有过渡层和表层双层结构,在层间构建了p-n复合结构;同时表层为ZnO、CuO和Cu2O的混合相,在物相间构建了p-n复合结构,由此利用Zn2+、Cu1+、Cu2+离子、表面纳米晶粒、金属氧化物间和层与层间的协同抗菌增强效应来获得优异的抗菌性;同时调控磁控溅射及后续退火工艺的各项工艺参数,赋予复合涂层中金属氧化物更为稳定的性质,更为致密的结构,提升复合涂层的耐腐蚀性;最终使复合涂层同时具有较好的耐腐蚀和抗菌性能表现,能满足金属植入物等对以上性能的需求,进而在其表面实现应用。The invention uses magnetron sputtering combined with subsequent annealing to prepare a corrosion-resistant and antibacterial composite coating; the composite coating has a transition layer and a surface layer double-layer structure, and a pn composite structure is constructed between the layers; at the same time, the surface layer is ZnO, CuO The mixed phase with Cu 2 O builds a pn composite structure between the phases, thus utilizing Zn 2+ , Cu 1+ , Cu 2+ ions, surface nano-grains, metal oxides and interlayer synergistic antibacterial Enhancement effect to obtain excellent antibacterial properties; at the same time, adjust the process parameters of magnetron sputtering and subsequent annealing process, endow the metal oxide in the composite coating with more stable properties and denser structure, and improve the composite coating. Corrosion resistance: Finally, the composite coating has good corrosion resistance and antibacterial performance at the same time, which can meet the needs of metal implants and other properties for the above properties, and then realize the application on its surface.
发明内容Contents of the invention
本发明基于金属植入物、医疗器械等生物医用材料对耐腐蚀性和抗菌性的双重需求,在规避前人研究缺陷的基础上,采用磁控溅射结合后续退火制备了一种具有ZnO过渡层和以ZnO、CuO和Cu2O混合物为表层的生物医用复合涂层;该复合涂层表现出较好的亲水性、耐体液腐蚀性和抗菌性,能满足植入材料的性能需求,适合作为功能性涂层应用于植入体表面。The present invention is based on the dual requirements of biomedical materials such as metal implants and medical devices for corrosion resistance and antibacterial properties. On the basis of avoiding the defects of previous studies, the invention adopts magnetron sputtering combined with subsequent annealing to prepare a ZnO transition layer and a biomedical composite coating with a mixture of ZnO, CuO and Cu 2 O as the surface layer; the composite coating exhibits good hydrophilicity, body fluid corrosion resistance and antibacterial properties, which can meet the performance requirements of implant materials. Suitable for application on implant surfaces as a functional coating.
本发明的目的在于提出一种耐腐蚀、抗菌生物医用复合涂层,是由ZnO、CuO和Cu2O三种材料组成,具有以50nm~100nm的ZnO过渡层以及150nm~500nm的ZnO、CuO和Cu2O复合层构建而成双层复合结构。The purpose of the present invention is to propose a corrosion-resistant, antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, and has a ZnO transition layer of 50nm to 100nm and a ZnO, CuO and CuO of 150nm to 500nm. The Cu 2 O composite layer is constructed to form a double-layer composite structure.
ZnO、CuO和Cu2O复合层截面为平均直径22nm~34nm、定向排列的纳米柱状晶,其表面为致密的15nm~60nm的细小晶粒结合针刺状凸起。The cross-section of the ZnO, CuO and Cu 2 O composite layer is nano-columnar crystals with an average diameter of 22nm-34nm and oriented arrangement, and the surface is dense fine crystal grains of 15nm-60nm combined with needle-like protrusions.
本发明所述生物医用复合涂层所选金属氧化物性质稳定、经磁控溅射和后续退火形成了致密的结构,还能够同时利用释放的金属离子、纳米晶粒以及物相和结构上的协同增强效应来抗菌灭菌,能满足植入材料对耐腐蚀性和抗菌性能的需求,因而适合作为功能性涂层应用于金属植入物、医疗器械等的表面。The metal oxides selected for the biomedical composite coating in the present invention are stable in properties, and form a compact structure through magnetron sputtering and subsequent annealing, and can also utilize the released metal ions, nanocrystal grains, and phase and structure The synergistic enhancement effect to antibacterial sterilization can meet the needs of implant materials for corrosion resistance and antibacterial performance, so it is suitable as a functional coating for the surface of metal implants, medical devices, etc.
本发明所述复合涂层,具有ZnO过渡层和以ZnO、CuO和Cu2O混合而成的表层,其复合不仅体现在过渡层和表层结构上,还在表层ZnO、CuO和Cu2O物相间实现;所具有的金属氧化物性质稳定、结构致密、物相间和结构间协同抗菌等优势能够赋予复合涂层较好的耐腐蚀性和抗菌性,适合作为生物功能性涂层在金属植入体、手术器械等医用材料表面上应用,以达到体内体外环境下保护医用材料本体并杀灭致病性微生物的双重目的。The composite coating of the present invention has a ZnO transition layer and a surface layer mixed with ZnO, CuO and Cu2O . Phase-to-phase realization; the advantages of stable metal oxide properties, compact structure, synergistic antibacterial between phases and structures can endow the composite coating with better corrosion resistance and antibacterial properties, and is suitable as a biofunctional coating in metal implants. It can be applied on the surface of medical materials such as bodies and surgical instruments to achieve the dual purpose of protecting the body of medical materials and killing pathogenic microorganisms in vivo and in vitro.
本发明的另一目的在于提供一种耐腐蚀、抗菌生物医用复合涂层的制备方法,磁控溅射结合后续退火处理;磁控溅射具有操作过程简单、产量高、产品成分可控等优点,主要能制备厚度可控、产物为纳米晶粒的涂层;后续退火能进一步强化产物的理化性质、消除内应力、通过促进晶粒生长来消除孔隙进一步提升涂层的致密性;本方法在制备复合涂层时,可通过调控Ar和O2的混合气体的体积分数、Zn靶/Cu靶的溅射功率、磁控溅射时间、退火温度、退火时间以及退火炉腔内压强来控制产物的物相成分、过渡层和表层厚度、截面及表面形貌等,从而改变复合涂层的耐腐蚀性能和抗菌性能,具体包括以下步骤:Another object of the present invention is to provide a method for preparing a corrosion-resistant and antibacterial biomedical composite coating, which combines magnetron sputtering with subsequent annealing treatment; magnetron sputtering has the advantages of simple operation process, high output, and controllable product components. , mainly capable of preparing coatings with controllable thickness and nano-grain products; subsequent annealing can further strengthen the physical and chemical properties of the products, eliminate internal stress, and eliminate pores by promoting grain growth to further improve the compactness of the coating; When preparing a composite coating, the product can be controlled by adjusting the volume fraction of the mixed gas of Ar and O2 , the sputtering power of the Zn target/Cu target, the magnetron sputtering time, the annealing temperature, the annealing time and the pressure in the annealing furnace chamber. The phase composition, transition layer and surface layer thickness, cross-section and surface morphology, etc., thereby changing the corrosion resistance and antibacterial performance of the composite coating, specifically including the following steps:
(1)将基底进行打磨,然后依次置于去离子水、无水乙醇和丙酮中超声清洗;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) The substrate was polished, and then placed in deionized water, absolute ethanol and acetone for ultrasonic cleaning; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,抽真空、设置样品台转速、调整溅射靶材与基底间的距离,调整工作气压,为磁控溅射做准备。(2) The Zn and Cu targets are symmetrically installed on the target position and kept at 45° to the horizontal direction; seal the magnetron sputtering chamber, vacuumize, set the sample stage speed, adjust the distance between the sputtering target and the substrate, and adjust Working air pressure in preparation for magnetron sputtering.
(3)在Ar和O2的混合气体气氛下,首先单独溅射Zn靶,在基底上沉积ZnO过渡层;而后调控Ar和O2混合气体的体积比,同时溅射Zn和Cu靶,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) In a mixed gas atmosphere of Ar and O 2 , first sputter the Zn target alone, and deposit a ZnO transition layer on the substrate; then adjust the volume ratio of the Ar and O 2 mixed gas, and sputter the Zn and Cu targets at the same time. A surface layer mixed with ZnO, CuO and Cu 2 O is deposited on the ZnO transition layer.
(4)从磁控溅射腔体内取出复合涂层后置于退火炉内,以N2作为保护气体进行退火处理,待自然冷却至室温后得到生物医用复合涂层。(4) The composite coating was taken out from the magnetron sputtering chamber and placed in an annealing furnace, annealed with N2 as a protective gas, and the biomedical composite coating was obtained after natural cooling to room temperature.
优选的,本发明步骤(1)中将基底分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨。Preferably, in the step (1) of the present invention, the substrate is polished step by step from coarse to fine with 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper.
优选的,本发明所述步骤(1)中的基底包括硅基片、钛基片、生物玻璃中的一种;步骤(2)中Zn、Cu金属靶材的纯度≥99%。Preferably, the substrate in step (1) of the present invention includes one of silicon substrate, titanium substrate, and bioglass; the purity of Zn and Cu metal targets in step (2) is ≥99%.
优选的,本发明为磁控溅射做准备的具体过程为:启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。Preferably, the specific process of preparing for magnetron sputtering in the present invention is: start the mechanical pump and the molecular pump to pump the vacuum in the sputtering chamber to 1×10 -4 Pa~2×10 -4 Pa, set the sample stage The rotating speed is 15r/min; the distance between the sputtering target and the substrate is adjusted to 100mm, and the working pressure during sputtering is controlled at 0.7Pa.
优选的,本发明所述步骤(3)在基底上磁控溅射制备ZnO过渡层时,混合气体中Ar和O2的相对含量按体积分数计,Ar为70%,O2为30%;溅射功率为25W~30W,溅射时间为30min~40min。Preferably, when step (3) of the present invention prepares the ZnO transition layer on the substrate by magnetron sputtering, Ar and O in the mixed gas Relative content by volume fraction, Ar is 70%, O 30 %; The sputtering power is 25W-30W, and the sputtering time is 30min-40min.
优选的,本发明所述步骤(3)在ZnO过渡层上同时溅射制备ZnO、CuO和Cu2O混合而成的表层时,混合气体中Ar和O2的相对含量按体积分数计,Ar为70%~90%,O2为10%~30%;Zn金属靶的溅射功率为45W~50W,Cu金属靶的溅射功率为35W~45W,溅射时间为10min~20min。Preferably, when step (3) of the present invention prepares a surface layer mixed with ZnO, CuO and Cu 2 O by simultaneous sputtering on the ZnO transition layer, the relative content of Ar and O in the mixed gas is calculated by volume fraction, Ar The sputtering power of Zn metal target is 45W-50W, the sputtering power of Cu metal target is 35W-45W, and the sputtering time is 10min-20min.
优选的,本发明步骤(4)退火处理时,其退火工艺参数温度为450℃~500℃,时间为1h~2h,腔内的压强为400Torr~430Torr,升温速率为1.5℃/s。Preferably, during the annealing treatment in step (4) of the present invention, the annealing process parameter temperature is 450°C-500°C, the time is 1h-2h, the pressure in the cavity is 400Torr-430Torr, and the heating rate is 1.5°C/s.
与现有的涂层相比,本发明的涂层为复合涂层,能够利用物相、结构上的协同效应提升杀菌灭菌能力;能够通过调控磁控溅射和后续退火参数获得致密的结构;使复合涂层能够同时具有较好的耐腐蚀性和抗菌性,能满足植入材料对上述性能的双重需求。Compared with the existing coating, the coating of the present invention is a composite coating, which can utilize the synergistic effect of phase and structure to improve the sterilization ability; it can obtain a dense structure by adjusting the parameters of magnetron sputtering and subsequent annealing ; The composite coating can have better corrosion resistance and antibacterial properties at the same time, and can meet the dual requirements of implant materials for the above-mentioned properties.
本发明的有益效果如下:The beneficial effects of the present invention are as follows:
(1)本发明制备的生物医用复合涂层,由ZnO、CuO和Cu2O三种金属氧化物组成,其极性离子共价键能够抵御水化,表现出耐腐蚀性;能够释放杀灭细菌的活性离子,表现出抗菌性;且作为半导体材料,能够用于构建p-n结。(1) The biomedical composite coating prepared by the present invention is composed of three metal oxides of ZnO, CuO and Cu 2 O, and its polar ion covalent bond can resist hydration and exhibit corrosion resistance; it can release and kill The active ions of bacteria exhibit antibacterial properties; and as semiconductor materials, they can be used to build pn junctions.
(2)本发明制备的生物医用复合涂层,具有过渡层和表层双层结构,能在层与层之间构建p-n结,利用产生的“活性氧”进一步提升自身的抗菌能力。(2) The biomedical composite coating prepared by the present invention has a double-layer structure of a transition layer and a surface layer, can build a p-n junction between layers, and use the generated "active oxygen" to further improve its antibacterial ability.
(3)本发明制备的生物医用复合涂层,其过渡层和表层的厚度可调,可分别达到50nm~100nm和150nm~500nm的范围。(3) The thickness of the transition layer and the surface layer of the biomedical composite coating prepared by the present invention can be adjusted to the ranges of 50nm-100nm and 150nm-500nm respectively.
(4)本发明制备的生物医用复合涂层,其表层为ZnO、CuO和Cu2O三种金属氧化物的混合物,能够在物相间构建p-n结;利用产生的“活性氧”进一步提升自身的抗菌能力。(4) The biomedical composite coating prepared by the present invention has a surface layer of a mixture of three metal oxides, ZnO, CuO and Cu 2 O, which can build a pn junction between phases; use the generated "active oxygen" to further improve its own Antibacterial ability.
(5)本发明制备的生物医用复合涂层,其表层截面为平均直径22nm~34nm、定向排列的纳米柱状晶,表现为致密结构,能够隔绝人体体液与植入材料间的接触。(5) The biomedical composite coating prepared by the present invention has a surface cross-section of nano columnar crystals with an average diameter of 22nm to 34nm and oriented arrangement, showing a compact structure, which can isolate the contact between human body fluids and implant materials.
(6)本发明制备的生物医用复合涂层,其表层表面为致密的15nm~60nm的细小晶粒结合针刺状凸起,致密的细小晶粒提升了涂层表面的致密性;同时针刺状凸起能够通过刺破微生物细胞壁来有效杀灭细菌。(6) The biomedical composite coating prepared by the present invention, its surface layer surface is dense 15nm~60nm fine grains combined with needle-like protrusions, and the dense fine grains have improved the compactness of the coating surface; The protuberances can effectively kill bacteria by piercing the cell wall of microorganisms.
(7)本发明制备的生物医用复合涂层,在表层表面致密的细小晶粒和针刺状凸起的共同作用下,其水接触角为9.18○±0.73○~28.75○±1.64○,表现出较好的亲水性。(7) The biomedical composite coating prepared by the present invention has a water contact angle of 9.18 ○ ±0.73 ○ to 28.75 ○ ±1.64 ○ under the joint action of the dense fine grains and needle-like protrusions on the surface layer, showing better hydrophilicity.
(8)本发明制备的生物医用复合涂层,在金属氧化物本身和致密结构的共同作用下,在模拟人体体液中其自腐蚀电位为-0.38V~-0.24V,显著大于钛基片-0.70V~-0.65V的自腐蚀电位,表现出对人体体液更好的耐腐蚀性能。(8) The biomedical composite coating prepared by the present invention has a self-corrosion potential of -0.38V~-0.24V in the simulated human body fluid under the joint action of the metal oxide itself and the dense structure, which is significantly greater than that of the titanium substrate- The self-corrosion potential of 0.70V~-0.65V shows better corrosion resistance to human body fluids.
(9)本发明制备的生物医用复合涂层,在释放的金属离子、表面针刺纳米晶、物相和结构协同增强的共同作用下,其对1×106CFU/ml大肠杆菌的抑菌率为93.2%~99.7%、对1×106CFU/ml金黄色葡萄球菌的抑菌率为91.0%~99.8%,均高于90%,表现出优异的杀菌灭菌效果。(9) The biomedical composite coating prepared by the present invention has a bacteriostatic effect on 1×10 6 CFU/ml E. The rate is 93.2%-99.7%, and the bacteriostasis rate against 1×10 6 CFU/ml Staphylococcus aureus is 91.0%-99.8%, all higher than 90%, showing excellent bactericidal effect.
(10)本发明制备的生物医用复合涂层,同时具有较好的耐腐蚀性和抗菌性。(10) The biomedical composite coating prepared by the present invention has good corrosion resistance and antibacterial property at the same time.
附图说明Description of drawings
图1为实施例1得到的生物医用复合涂层的X射线衍射(XRD)图谱。Fig. 1 is the X-ray diffraction (XRD) pattern of the biomedical composite coating obtained in Example 1.
图2为实施例2得到的生物医用复合涂层在扫描电镜(SEM)下的表面形貌。Figure 2 is the surface morphology of the biomedical composite coating obtained in Example 2 under a scanning electron microscope (SEM).
图3为实施例3得到的生物医用复合涂层在扫描电镜(SEM)下的截面形貌。Figure 3 is the cross-sectional morphology of the biomedical composite coating obtained in Example 3 under a scanning electron microscope (SEM).
图4为实施例1得到的生物医用复合涂层原子力显微镜(AFM)的3D表面微观形貌。Fig. 4 is the 3D surface microscopic morphology of the biomedical composite coating obtained in Example 1 by an atomic force microscope (AFM).
图5为实施例1得到的生物医用复合涂层的(a)紫外可见光漫反射光谱(UV-VisDRS)和(b)光致发光光谱(PL)。Figure 5 is (a) UV-Vis Diffuse Reflectance Spectrum (UV-VisDRS) and (b) Photoluminescence Spectrum (PL) of the biomedical composite coating obtained in Example 1.
图6为实施例1得到的生物医用复合涂层以及金属钛片基底的动电位极化Tafel曲线对比图。Fig. 6 is a comparison diagram of the potentiodynamic polarization Tafel curves of the biomedical composite coating obtained in Example 1 and the metal titanium sheet substrate.
图7为实施例1得到的金属钛片基底(a)和生物医用复合涂层(b)的水接触角测试图。Fig. 7 is the water contact angle test diagram of the metal titanium sheet substrate (a) and the biomedical composite coating (b) obtained in Example 1.
图8为实施例1得到的生物医用复合涂层以及金属钛片与目标菌种大肠杆菌和金黄色葡萄球菌直接接触1h后,再对细菌悬液培养24h的菌落照片。Fig. 8 is a photo of the colonies of the biomedical composite coating obtained in Example 1 and the metal titanium sheet directly contacted with the target bacteria Escherichia coli and Staphylococcus aureus for 1 hour, and then cultured on the bacterial suspension for 24 hours.
具体实施方式Detailed ways
以下实施例是针对本发明的材料特征和制备方法所展开的一系列详细描述,不能凭此理解为是对本发明权利要求的限制。还需指出的是,在不脱离本发明构思的前提下所做出的若干替换和改进,都属于本发明的保护范围。如未特别说明,本发明使用的原料均为市购常规产品,最低级别为分析纯。The following examples are a series of detailed descriptions aimed at the material characteristics and preparation methods of the present invention, which should not be construed as limiting the claims of the present invention. It should also be pointed out that several replacements and improvements made without departing from the concept of the present invention all belong to the protection scope of the present invention. Unless otherwise specified, the raw materials used in the present invention are commercially available conventional products, and the lowest grade is analytically pure.
实施例1Example 1
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为50nm的ZnO,表层为150nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径22nm、定向排列的纳米柱状晶,表面为致密的15nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 50nm of ZnO, and the surface layer is 150nm of ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 22nm and oriented arrangement, and the surface is dense 15nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用金属钛片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于去离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Use metal titanium sheets as the base, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Ultrasonic cleaning in water, ethanol and acetone for 30 min each; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以25W的溅射功率单独溅射Zn靶并持续30min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至90%和10%,分别以45W、35W的溅射功率同时溅射Zn靶、Cu靶并持续10min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, sputter the Zn target separately with a sputtering power of 25W and continue for 30min, and deposit ZnO transition on the substrate first. layer; then adjust the Ar and O 2 volume fraction content in the Ar/O 2 mixed gas atmosphere to 90% and 10%, and sputter the Zn target and the Cu target at the same time with the sputtering power of 45W and 35W respectively and continue for 10min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在450℃温度下退火处理1h,期间保证炉腔内的压强为400Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于金属钛片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at 450 °C for 1 h with N2 as a protective gas, during which the pressure in the furnace cavity was guaranteed to be 400 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, a composite coating on the metal titanium sheet is obtained.
对实施例1所述生物医用复合涂层进行X射线衍射表征,其表征图谱结果如图1所示;由图1可知,复合涂层产生的X射线衍射峰,其强度、峰位能够与JCPDS标准卡片36-1451、89-2529、78-2076相互对应,证实复合涂层的表层产物为ZnO、CuO及Cu2O的混合物。The biomedical composite coating described in Example 1 is characterized by X-ray diffraction, and the characterization spectrum results are as shown in Figure 1; As can be seen from Figure 1, the X-ray diffraction peak produced by the composite coating has an intensity and peak position comparable to that of JCPDS The standard cards 36-1451, 89-2529, and 78-2076 correspond to each other, confirming that the surface layer product of the composite coating is a mixture of ZnO, CuO and Cu 2 O.
实施例2Example 2
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为100nm的ZnO,表层为500nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径34nm、定向排列的纳米柱状晶,表面为致密的60nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 100nm of ZnO, and the surface layer is 500nm of ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 34nm and aligned alignment, and the surface is dense 60nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用Bioglass45S5生物玻璃片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Choose Bioglass45S5 biological glass sheet as the substrate, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Ultrasonic cleaning in water, ethanol and acetone for 30 min each; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以30W的溅射功率单独溅射Zn靶并持续40min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至70%和30%,分别以50W、45W的溅射功率同时溅射Zn靶、Cu靶并持续20min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, the Zn target is sputtered separately with a sputtering power of 30W and lasts for 40min, and the ZnO transition is first deposited on the substrate. layer; then adjust the Ar and O 2 volume fraction content in the Ar/O 2 mixed gas atmosphere to 70% and 30%, and sputter the Zn target and the Cu target simultaneously with the sputtering power of 50W and 45W respectively and continue for 20min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在500℃温度下退火处理2h,期间保证炉腔内的压强为430Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于Bioglass45S5生物玻璃片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at a temperature of 500 °C for 2 h with N2 as a protective gas, during which the pressure in the furnace cavity was ensured to be 430 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, the composite coating on the Bioglass45S5 biological glass sheet was obtained.
对实施例2所述生物医用复合涂层的表面进行扫描电镜(SEM)表征,且结果如图2所示;由图2可知,复合涂层的表面上存在大量向上生长的针刺状凸起,这些凸起是溅射沉积的部分纳米柱状晶依靠定向生长优势而形成的;在这些凸起下方,存在平均粒径不超过60nm的细小晶粒;凸起与晶粒彼此间相互紧密排列为复合涂层提供了一个致密的表面。The surface of the biomedical composite coating described in Example 2 is characterized by a scanning electron microscope (SEM), and the results are as shown in Figure 2; As can be seen from Figure 2, there are a large number of needle-like protrusions growing upwards on the surface of the composite coating , these protrusions are formed by the sputtering deposition of some nano-columnar crystals relying on the advantage of directional growth; under these protrusions, there are fine grains with an average particle size of no more than 60nm; the protrusions and the grains are closely arranged with each other as Composite coatings provide a dense surface.
实施例3Example 3
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为78nm的ZnO,表层为422nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径30nm、定向排列的纳米柱状晶,表面为致密的30nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 78nm ZnO, and the surface layer is 422nm ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 30nm and aligned alignment, and the surface is dense 30nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用纯硅片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Use pure silicon wafers as the base, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Each of ethanol and acetone was ultrasonically cleaned for 30 min; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以28W的溅射功率单独溅射Zn靶并持续30min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至80%和20%,分别以45W、40W的溅射功率同时溅射Zn靶、Cu靶并持续12min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, sputter the Zn target separately with 28W sputtering power and continue for 30min, deposit ZnO transition first on the substrate layer; then adjust the Ar and O 2 volume fraction content in the Ar/O 2 mixed gas atmosphere to 80% and 20%, and sputter the Zn target and the Cu target at the same time with the sputtering power of 45W and 40W respectively and continue for 12min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在470℃温度下退火处理1.2h,期间保证炉腔内的压强为415Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于纯硅片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at a temperature of 470 °C for 1.2 h with N2 as a protective gas. During this period, the pressure in the furnace cavity was guaranteed to be 415 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, a composite coating on a pure silicon wafer is obtained.
对实施例3所述生物医用复合涂层的截面进行扫描电镜(SEM)表征,且结果如图3所示;由图3可知,复合涂层中的表层从截面上看其形貌表现为平均直径不超过30nm、各晶粒定向排列的纳米柱状晶;在柱状晶的中下部存在一条较为明显的分界线,这是ZnO过渡层和ZnO、CuO和Cu2O混合而成的表层间的界面,证实该复合涂层具有双层复合结构;经测量,过渡层厚度为78nm,表层厚度为422nm。The section of the biomedical composite coating described in
实施例4Example 4
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为80nm的ZnO,表层为450nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径24nm、定向排列的纳米柱状晶,表面为致密的38nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 80nm of ZnO, and the surface layer is 450nm of ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 24nm and aligned alignment, and the surface is dense 38nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用钛铝合金片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Use titanium-aluminum alloy sheets as the base, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Ultrasonic cleaning in water, ethanol and acetone for 30 min each; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以26W的溅射功率单独溅射Zn靶并持续35min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至85%和15%,分别以47W、38W的溅射功率同时溅射Zn靶、Cu靶并持续15min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, sputter the Zn target separately with 26W sputtering power and continue for 35min, deposit ZnO transition first on the substrate layer; then adjust the Ar and O 2 volume fraction content to 85% and 15% in the Ar/O 2 mixed gas atmosphere, and sputter the Zn target and the Cu target at the same time with the sputtering power of 47W and 38W respectively and continue for 15min, and the ZnO transition A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在460℃温度下退火处理1.7h,期间保证炉腔内的压强为425Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于钛铝合金片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at 460 °C for 1.7 h with N 2 as the protective gas. During this period, the pressure in the furnace cavity was guaranteed to be 425 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, a composite coating on the titanium-aluminum alloy sheet is obtained.
实施例5Example 5
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为72nm的ZnO,表层为408nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径23nm、定向排列的纳米柱状晶,表面为致密的28nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 72nm ZnO, and the surface layer is 408nm ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 23nm and aligned alignment, and the surface is dense 28nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用Bioglass45S5生物玻璃片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Choose Bioglass45S5 biological glass sheet as the substrate, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Ultrasonic cleaning in water, ethanol and acetone for 30 min each; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以28W的溅射功率单独溅射Zn靶并持续32min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至88%和12%,分别以48W、35W的溅射功率同时溅射Zn靶、Cu靶并持续10min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, the Zn target is sputtered separately with a sputtering power of 28W and lasts for 32min, and the ZnO transition is first deposited on the substrate. layer; then adjust the Ar and O 2 volume fraction content in the Ar/O 2 mixed gas atmosphere to 88% and 12%, and sputter the Zn target and the Cu target simultaneously with the sputtering power of 48W and 35W respectively and continue for 10min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在450℃温度下退火处理1.3h,期间保证炉腔内的压强为410Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于Bioglass45S5生物玻璃片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at 450 °C for 1.3 h with N 2 as the protective gas. During this period, the pressure in the furnace cavity was guaranteed to be 410 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, the composite coating on the Bioglass45S5 biological glass sheet was obtained.
实施例6Example 6
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为95nm的ZnO,表层为220nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径30nm、定向排列的纳米柱状晶,表面为致密的45nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 95nm ZnO, and the surface layer is 220nm ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 30nm and aligned alignment, and the surface is dense 45nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用金属钛片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Use metal titanium sheets as the base, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; then place them in ionized water, anhydrous Each of ethanol and acetone was ultrasonically cleaned for 30 min; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以29W的溅射功率单独溅射Zn靶并持续38min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至75%和25%,分别以45W、37W的溅射功率同时溅射Zn靶、Cu靶并持续13min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, sputter the Zn target separately with 29W sputtering power and continue for 38min, deposit ZnO transition first on the substrate layer; then adjust the Ar and O 2 volume fraction content to 75% and 25% in the Ar/O 2 mixed gas atmosphere, and sputter the Zn target and the Cu target simultaneously with the sputtering power of 45W and 37W respectively and last for 13min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在480℃温度下退火处理1.1h,期间保证炉腔内的压强为405Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于金属钛片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at 480 °C for 1.1 h with N2 as the protective gas. During this period, the pressure in the furnace cavity was guaranteed to be 405 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, a composite coating on the metal titanium sheet is obtained.
实施例7Example 7
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为95nm的ZnO,表层为420nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径28nm、定向排列的纳米柱状晶,表面为致密的52nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 95nm ZnO, and the surface layer is 420nm ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 28nm and aligned alignment, and the surface is dense 52nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用纯金属钛片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Select pure metal titanium sheets as the base, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Ultrasonic cleaning in water, ethanol and acetone for 30 min each; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以30W的溅射功率单独溅射Zn靶并持续40min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至78%和22%,分别以45W、45W的溅射功率同时溅射Zn靶、Cu靶并持续20min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, the Zn target is sputtered separately with a sputtering power of 30W and lasts for 40min, and the ZnO transition is first deposited on the substrate. layer; then adjust the Ar and O 2 volume fraction content in the Ar/O 2 mixed gas atmosphere to 78% and 22%, and sputter the Zn target and the Cu target at the same time with the sputtering power of 45W and 45W respectively and continue for 20min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在500℃温度下退火处理2h,期间保证炉腔内的压强为415Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于金属钛片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at a temperature of 500 °C for 2 h with N2 as a protective gas, during which the pressure in the furnace cavity was ensured to be 415 Torr, and the heating rate was 1.5 °C/s. After naturally cooling to room temperature, a composite coating on the metal titanium sheet is obtained.
实施例8Example 8
一种耐腐蚀、抗菌生物医用复合涂层,由ZnO、CuO和Cu2O三种材料组成,具有过渡层和表层双层复合结构;过渡层为55nm的ZnO,表层为385nm的ZnO、CuO和Cu2O混合物;表层截面为平均直径30nm、定向排列的纳米柱状晶,表面为致密的48nm细小晶粒结合针刺状凸起。A corrosion-resistant and antibacterial biomedical composite coating, which is composed of three materials: ZnO, CuO and Cu 2 O, has a transition layer and a surface layer with a double-layer composite structure; the transition layer is 55nm ZnO, and the surface layer is 385nm ZnO, CuO and Cu 2 O mixture; the surface section is nano-columnar crystals with an average diameter of 30nm and aligned alignment, and the surface is dense 48nm fine grains combined with needle-like protrusions.
本实施例所述生物医用复合涂层的制备方法为磁控溅射结合后续退火处理工艺,具体包括以下步骤:The preparation method of the biomedical composite coating described in this embodiment is magnetron sputtering combined with a subsequent annealing process, which specifically includes the following steps:
(1)选用纯金属钛片为基底,分别用200目、400目、600目、800目、1000目、1200目、1500目砂纸由粗到细逐级打磨;然后依次置于离子水、无水乙醇和丙酮中各超声清洗30min;并用N2枪对基底吹扫干净后固定在磁控溅射腔内的样品台上。(1) Select pure metal titanium sheets as the base, and use 200 mesh, 400 mesh, 600 mesh, 800 mesh, 1000 mesh, 1200 mesh, and 1500 mesh sandpaper to polish step by step from coarse to fine; Ultrasonic cleaning in water, ethanol and acetone for 30 min each; and the substrate was purged with N2 gun and fixed on the sample stage in the magnetron sputtering chamber.
(2)将纯度≥99%的Zn和Cu靶对称安装在靶位上,并保持与水平方向呈45°;密封磁控溅射腔,启用机械泵和分子泵将溅射腔内的真空度抽至1×10-4Pa~2×10-4Pa,设置样品台的转速为15r/min;将溅射靶材与基底间的距离调整为100mm,溅射时的工作气压控制在0.7Pa。(2) Install the Zn and Cu targets with a purity of ≥99% symmetrically on the target position, and keep it at 45° to the horizontal direction; seal the magnetron sputtering chamber, use the mechanical pump and the molecular pump to reduce the vacuum in the sputtering chamber Pump to 1×10 -4 Pa~2×10 -4 Pa, set the rotation speed of the sample stage to 15r/min; adjust the distance between the sputtering target and the substrate to 100mm, and control the working pressure at 0.7Pa during sputtering .
(3)在Ar、O2体积分数含量分别为70%和30%的Ar/O2混合气体气氛下,以27W的溅射功率单独溅射Zn靶并持续31min,在基底上首先沉积ZnO过渡层;然后调整Ar/O2混合气体气氛中Ar和O2体积分数含量至84%和16%,分别以48W、42W的溅射功率同时溅射Zn靶、Cu靶并持续17min,在ZnO过渡层上沉积ZnO、CuO和Cu2O混合而成的表层。(3) Under the Ar/ O mixed gas atmosphere with Ar and O2 volume fraction contents of 70% and 30% respectively, the Zn target was sputtered separately with a sputtering power of 27W and lasted for 31min, and the ZnO transition was first deposited on the substrate. layer; then adjust the Ar and O 2 volume fraction content to 84% and 16% in the Ar/O 2 mixed gas atmosphere, and sputter the Zn target and Cu target simultaneously with the sputtering power of 48W and 42W respectively and continue for 17min. A surface layer composed of ZnO, CuO and Cu 2 O is deposited on the layer.
(4)将上述复合涂层再次置于退火炉内,以N2作为保护气体在475℃温度下退火处理1.6h,期间保证炉腔内的压强为425Torr,升温速率为1.5℃/s。待自然冷却至室温后得到位于纯金属钛片上的复合涂层。(4) The above composite coating was placed in the annealing furnace again, and annealed at a temperature of 475 °C for 1.6 h with N2 as a protective gas, during which the pressure in the furnace cavity was guaranteed to be 425 Torr, and the heating rate was 1.5 °C/s. After being naturally cooled to room temperature, a composite coating on a pure metal titanium sheet is obtained.
为了研究本发明制备得到的生物医用复合涂层的相关性能,本发明随机选择实施例1所得生物医用复合涂层进行检测,具体结果分析如下:In order to study the relevant properties of the biomedical composite coating prepared by the present invention, the present invention randomly selects the biomedical composite coating obtained in Example 1 for detection, and the specific results are analyzed as follows:
对实施例1所述生物医用复合涂层的截面进行原子力显微镜(AFM)表征,其表面微观3D形貌如图4所示;由图4可知,复合涂层表面是由数量较多的矮小晶粒和数量较少的高大晶粒相互紧密接触构成,这与SEM电镜观测的结果基本一致,高大晶粒为针刺状凸起,而矮小晶粒则对应那些致密的细小晶粒。The cross-section of the biomedical composite coating described in Example 1 is characterized by atomic force microscopy (AFM), and its surface microscopic 3D morphology is as shown in Figure 4; as can be seen from Figure 4, the surface of the composite coating is composed of a large number of dwarf crystals. The tall grains and a small number of tall grains are in close contact with each other, which is basically consistent with the results of the SEM electron microscope observation. The tall grains are needle-like protrusions, while the short grains correspond to those dense and fine grains.
实施例2~8所得生物医用复合涂层的形貌与实施例1相似,复合涂层表面是由数量较多的矮小晶粒和数量较少的高大晶粒相互紧密接触构成。The morphology of the biomedical composite coating obtained in Examples 2-8 is similar to that of Example 1. The surface of the composite coating is composed of a large number of short grains and a small number of tall grains in close contact with each other.
对实施例1所述生物医用复合涂层进行光学特性表征,分别测试在波长范围为300nm~800nm内的紫外-可见光漫反射光谱以及在285nm激发波长下的光致发光光谱,以研究该复合涂层的光吸收能力和可见光产生的电子-空穴对的复合速率;并与无涂层的Bioglass45S5生物玻璃片作对比,记录两种光谱如图5(a)和(b)所示。由图5(a)的紫外-可见光漫反射光谱可知,在波长为400nm~800nm可见光范围内,上述复合涂层的吸收强度远高于无涂层的Bioglass45S5生物玻璃,这种吸收行为从理论上保证了上述复合涂层具有优异的光催化性能。由图5(b)的光致发光光谱可知,生物玻璃片的荧光强度要远高于复合涂层,发光强度降低通常意味着光激发的辐射复合程度降低,其光催化活性升高,这表明ZnO和CuO(Cu2O)的复合抑制了电子-空穴复合,在复合涂层中形成了良好的异质结结构;紫外-可见光漫反射光谱与光致发光光谱均表明复合涂层中两种类型的半导体材料结合有助于提高光催化效率,从而促进产生“活性氧”。The optical characteristics of the biomedical composite coating described in Example 1 were characterized, and the ultraviolet-visible light diffuse reflectance spectrum in the wavelength range of 300nm to 800nm and the photoluminescence spectrum at an excitation wavelength of 285nm were respectively tested to study the composite coating. The light absorption ability of the layer and the recombination rate of electron-hole pairs generated by visible light; and compared with the uncoated Bioglass45S5 bioglass sheet, the two spectra were recorded as shown in Figure 5 (a) and (b). From the ultraviolet-visible light diffuse reflectance spectrum in Figure 5(a), it can be seen that the absorption intensity of the above-mentioned composite coating is much higher than that of the uncoated Bioglass45S5 bioglass in the range of visible light with a wavelength of 400nm to 800nm. This absorption behavior is theoretically The above composite coatings are guaranteed to have excellent photocatalytic properties. From the photoluminescence spectrum in Figure 5(b), it can be seen that the fluorescence intensity of the bioglass sheet is much higher than that of the composite coating, and the decrease in luminescence intensity usually means that the recombination degree of photoexcited radiation is reduced, and its photocatalytic activity is increased, which indicates that The recombination of ZnO and CuO(Cu 2 O) inhibits electron-hole recombination and forms a good heterojunction structure in the composite coating. The combination of these types of semiconductor materials helps to improve photocatalytic efficiency, thereby promoting the generation of "active oxygen species".
实施例2~8所得生物医用复合涂层的性质与实施例1相似,复合涂层中两种类型的半导体材料结合有助于提高光催化效率,从而促进产生“活性氧”。The properties of the biomedical composite coating obtained in Examples 2-8 are similar to those in Example 1. The combination of two types of semiconductor materials in the composite coating helps to improve the photocatalytic efficiency, thereby promoting the generation of "active oxygen".
以模拟人体体液为电解液,上述生物医用复合涂层作为工作电极,金属铂片为负极,饱和甘汞电极为参比电极,采用CHI600E型电化学工作站展开动电位极化测试,并与无涂层的纯金属钛片作对比。测试时通过1800s建立平衡开路电位(Eocp),然后以0.01V/s的扫描速度记录动电位Tafel极化曲线,并对检测的Tafel曲线进行线性外推,得到样品的腐蚀电位(Ecorr)和腐蚀电流密度(Icorr)等关键参数,其Tafel曲线如图6所示。由图6可知,Tafel曲线的尖端所对应的电位为自腐蚀电位(Ecorr),其电位越正代表材料在模拟人体体液中发生腐蚀的倾向越低。与纯钛片基底为-0.68V的Ecorr相比,复合涂层的自腐蚀电位朝着正电位方向发生明显移动,具有更高的Ecorr(-0.25V),说明其耐腐蚀能力更为优异,能够较好的保护好基底材料。Using the simulated human body fluid as the electrolyte, the above-mentioned biomedical composite coating as the working electrode, the metal platinum sheet as the negative electrode, and the saturated calomel electrode as the reference electrode, a CHI600E electrochemical workstation was used to carry out the potentiodynamic polarization test, and compared with the non-coated layer of pure titanium metal for comparison. During the test, the equilibrium open circuit potential (E ocp ) was established through 1800s, and then the potentiodynamic Tafel polarization curve was recorded at a scanning speed of 0.01V/s, and the detected Tafel curve was linearly extrapolated to obtain the corrosion potential (E corr ) of the sample And key parameters such as corrosion current density (I corr ), the Tafel curve is shown in Figure 6. It can be seen from Figure 6 that the potential corresponding to the tip of the Tafel curve is the self-corrosion potential (E corr ), and the more positive the potential, the lower the tendency of the material to corrode in the simulated human body fluid. Compared with the E corr of -0.68V for the pure titanium sheet substrate, the self-corrosion potential of the composite coating shifted significantly to the positive potential direction, with a higher E corr (-0.25V), indicating that its corrosion resistance is better Excellent, can better protect the base material.
实施例2~8所得生物医用复合涂层的性质与实施例1相似,耐腐蚀能力优异,能够较好的保护好基底材料。The properties of the biomedical composite coatings obtained in Examples 2 to 8 are similar to those in Example 1, with excellent corrosion resistance and better protection of the base material.
以去离子水为水接触角测试液,采用SL200KS型专业接触角仪对实施例1所述生物医用复合涂层展开润湿性测试,并与无涂层的纯金属钛片为对比;通过杨氏方程计算液滴自由下落到样品表面时两者相接触产生的角度,其水接触润湿角如图7所示;由图7(a)可知,纯金属钛片的水接触角为77.37○±1.85○,小于90○,表现为亲水性;在钛金属表面沉积复合涂层后,其所示的水接触角如图7(b)所示,已经进一步缩小至14.18○±0.77○,在针刺状凸起和细小颗粒共同贡献的更高表面粗糙度辅助下,亲水性得到进一步提高。With deionized water as the water contact angle test solution, the wettability test of the biomedical composite coating described in Example 1 was carried out by using the SL200KS type professional contact angle meter, and compared with the pure metal titanium sheet without coating; by Yang The equation calculates the angle at which the two contact each other when the droplet falls freely on the sample surface, and its water contact wetting angle is shown in Figure 7; it can be seen from Figure 7(a) that the water contact angle of a pure metal titanium sheet is 77.37 ○ ±1.85 ○ , less than 90 ○ , showing hydrophilicity; after the composite coating is deposited on the surface of titanium metal, the water contact angle shown in Figure 7(b) has been further reduced to 14.18 ○ ±0.77 ○ , The hydrophilicity is further enhanced with the aid of higher surface roughness contributed by both needle-like protrusions and fine particles.
实施例2~8所得生物医用复合涂层的性质与实施例1相似,亲水性得到进一步提高。The properties of the biomedical composite coatings obtained in Examples 2-8 are similar to those in Example 1, and the hydrophilicity is further improved.
用平板菌落计数法检测所制备的复合涂层对大肠杆菌和金黄色葡萄球菌的抑菌能力;用移液枪吸取100μL比浊浓度为1×106CFU/ml的金黄色葡萄球菌和大肠杆菌悬浮液,分别缓慢滴定在消毒处理后的样品表面,在静置1h后,迅速用移液枪吸取无菌生理盐水冲洗样品表面至反应后的菌液稀释100倍,接着用移液枪吸取100μL稀释后的细菌悬液并涂布于营养琼脂培养基上,在37℃下继续培养24h,细菌在琼脂平板上的菌落如图8所示;由图8可知,无论是大肠杆菌还是金黄色葡萄球菌,与纯金属钛片接触后细菌增殖不受影响,其菌落布满整个琼脂平板,与细菌悬液直接培养的结果类似,这说明纯金属钛片没有杀菌抑菌的效果。与之对比,接触过复合涂层的细菌悬液在后续琼脂板上的培养菌落数出现大幅度减少,对两种细菌都具有明显的杀灭作用,表现出较好的广谱抗菌性,以纯金属钛片作对照组,该复合涂层针对大肠杆菌、金黄色葡萄球菌的抑菌率分别为95.5%和93.1%,都大于90%,具有强烈的杀菌灭菌作用。The antibacterial ability of the prepared composite coating against Escherichia coli and Staphylococcus aureus was detected by plate colony counting method; 100 μL of Staphylococcus aureus and Escherichia coli with a turbidimetric concentration of 1×10 6 CFU/ml were drawn with a pipette gun The suspension was slowly titrated on the surface of the sterilized sample, and after standing for 1 hour, quickly use a pipette to draw sterile saline to rinse the surface of the sample until the reacted bacterial solution was diluted 100 times, and then use a pipette to absorb 100 μL The diluted bacterial suspension was spread on the nutrient agar medium, and continued to cultivate at 37°C for 24 hours. The colonies of the bacteria on the agar plate were shown in Figure 8; Bacteria, after contact with the pure metal titanium sheet, the bacterial proliferation is not affected, and its colony covers the entire agar plate, which is similar to the result of direct culture of the bacterial suspension, which shows that the pure metal titanium sheet has no bactericidal and antibacterial effect. In contrast, the number of cultured colonies on the subsequent agar plate of the bacterial suspension that had been exposed to the composite coating was greatly reduced, and it had obvious killing effects on both bacteria, showing better broad-spectrum antibacterial properties. The metal titanium sheet was used as the control group. The antibacterial rates of the composite coating against Escherichia coli and Staphylococcus aureus were 95.5% and 93.1%, respectively, both of which were greater than 90%, showing a strong bactericidal effect.
实施例2~8所得生物医用复合涂层的性质与实施例1相似,具有强烈的杀菌灭菌作用。The properties of the biomedical composite coatings obtained in Examples 2-8 are similar to those in Example 1, and have strong bactericidal and sterilizing effects.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310231767.4A CN116288203B (en) | 2023-03-10 | 2023-03-10 | Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310231767.4A CN116288203B (en) | 2023-03-10 | 2023-03-10 | Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116288203A true CN116288203A (en) | 2023-06-23 |
| CN116288203B CN116288203B (en) | 2024-07-19 |
Family
ID=86831907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310231767.4A Active CN116288203B (en) | 2023-03-10 | 2023-03-10 | Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116288203B (en) |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01303150A (en) * | 1988-06-01 | 1989-12-07 | Asahi Chem Ind Co Ltd | Moisture permeable film containing copper ion and/or silver ion |
| CN102511503A (en) * | 2011-12-06 | 2012-06-27 | 海南大学 | Efficient and environmentally-friendly antibacterial and mildewproof inorganic composite nano-powder slurry and its preparation method |
| US20130022835A1 (en) * | 2011-07-20 | 2013-01-24 | Hon Hai Precision Industry Co., Ltd. | Coated article having antibacterial effect and method for making the same |
| CN103132045A (en) * | 2011-11-28 | 2013-06-05 | 英作纳米科技(北京)有限公司 | Preparation method for coatings of medical supplies and products thereof |
| CN105660696A (en) * | 2016-01-08 | 2016-06-15 | 南昌大学 | Preparation method of visible light excitation antibacterial coating layer containing nano cuprous oxide |
| JP2017000655A (en) * | 2015-06-16 | 2017-01-05 | 日本板硝子株式会社 | Substrate with antiviral thin film |
| US20170231229A1 (en) * | 2016-02-15 | 2017-08-17 | Glas Troesch Holding Ag | Antimicrobial glass coating |
| CN107304472A (en) * | 2016-04-18 | 2017-10-31 | 中国科学院上海硅酸盐研究所 | Have medical titanium-based composite coat of Bone Defect Repari function and anti-microbial property and preparation method thereof concurrently |
| US20190246635A1 (en) * | 2016-09-20 | 2019-08-15 | Agency For Science, Technology And Research | Cell Rupture-Based Antimicrobial Surfaces Coated With Metal Oxide Nano-Arrays |
| US20190246636A1 (en) * | 2016-09-20 | 2019-08-15 | Agency For Science, Technology And Research | Redox Active Metal/Metal Oxide Composites For Antimicrobial Applications |
| CN110157225A (en) * | 2019-04-15 | 2019-08-23 | 太原理工大学 | A kind of preparation method of metal surface graphene-antibacterial antifouling anticorrosion composite coating |
| CN115335341A (en) * | 2020-04-09 | 2022-11-11 | 依视路国际公司 | Optical product with antibacterial function |
| CN218059716U (en) * | 2022-05-30 | 2022-12-16 | 大冶市好斯莱装饰材料有限公司 | Environment-friendly antibacterial wood-grain paper structure |
| KR20220168522A (en) * | 2021-06-16 | 2022-12-23 | 리그마글라스 주식회사 | Antibacterial glass coated with nanocomposite and manufacturing method thereof |
| CN115624966A (en) * | 2022-10-13 | 2023-01-20 | 中国科学院深圳先进技术研究院 | Metal oxide composite material and preparation method and application thereof |
-
2023
- 2023-03-10 CN CN202310231767.4A patent/CN116288203B/en active Active
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01303150A (en) * | 1988-06-01 | 1989-12-07 | Asahi Chem Ind Co Ltd | Moisture permeable film containing copper ion and/or silver ion |
| US20130022835A1 (en) * | 2011-07-20 | 2013-01-24 | Hon Hai Precision Industry Co., Ltd. | Coated article having antibacterial effect and method for making the same |
| CN103132045A (en) * | 2011-11-28 | 2013-06-05 | 英作纳米科技(北京)有限公司 | Preparation method for coatings of medical supplies and products thereof |
| CN102511503A (en) * | 2011-12-06 | 2012-06-27 | 海南大学 | Efficient and environmentally-friendly antibacterial and mildewproof inorganic composite nano-powder slurry and its preparation method |
| JP2017000655A (en) * | 2015-06-16 | 2017-01-05 | 日本板硝子株式会社 | Substrate with antiviral thin film |
| CN105660696A (en) * | 2016-01-08 | 2016-06-15 | 南昌大学 | Preparation method of visible light excitation antibacterial coating layer containing nano cuprous oxide |
| US20170231229A1 (en) * | 2016-02-15 | 2017-08-17 | Glas Troesch Holding Ag | Antimicrobial glass coating |
| CN107304472A (en) * | 2016-04-18 | 2017-10-31 | 中国科学院上海硅酸盐研究所 | Have medical titanium-based composite coat of Bone Defect Repari function and anti-microbial property and preparation method thereof concurrently |
| US20190246635A1 (en) * | 2016-09-20 | 2019-08-15 | Agency For Science, Technology And Research | Cell Rupture-Based Antimicrobial Surfaces Coated With Metal Oxide Nano-Arrays |
| US20190246636A1 (en) * | 2016-09-20 | 2019-08-15 | Agency For Science, Technology And Research | Redox Active Metal/Metal Oxide Composites For Antimicrobial Applications |
| CN110157225A (en) * | 2019-04-15 | 2019-08-23 | 太原理工大学 | A kind of preparation method of metal surface graphene-antibacterial antifouling anticorrosion composite coating |
| CN115335341A (en) * | 2020-04-09 | 2022-11-11 | 依视路国际公司 | Optical product with antibacterial function |
| KR20220168522A (en) * | 2021-06-16 | 2022-12-23 | 리그마글라스 주식회사 | Antibacterial glass coated with nanocomposite and manufacturing method thereof |
| CN218059716U (en) * | 2022-05-30 | 2022-12-16 | 大冶市好斯莱装饰材料有限公司 | Environment-friendly antibacterial wood-grain paper structure |
| CN115624966A (en) * | 2022-10-13 | 2023-01-20 | 中国科学院深圳先进技术研究院 | Metal oxide composite material and preparation method and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| B. UMA等: "Controlled synthesis of (CuO-Cu2O)Cu/ZnO multi oxide nanocomposites by facile combustion route: A potential photocatalytic, antimicrobial and anticancer activity", 《CERAMICS INTERNATIONAL》, vol. 47, no. 10, 24 September 2020 (2020-09-24), pages 14829 - 14844 * |
| 潘张翼等: "骨科植入物表面细菌生物膜形成及植入物表面的抗菌改性", 《中国组织工程研究与临床康复》, vol. 14, no. 43, 22 October 2010 (2010-10-22), pages 8090 - 8094 * |
| 王野等: "纳米氧化亚铜的制备及其应用的研究进展", 《化学世界》, no. 9, 25 September 2011 (2011-09-25), pages 573 - 576 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116288203B (en) | 2024-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sivaraj et al. | Enhanced antibacterial and corrosion resistance properties of Ag substituted hydroxyapatite/functionalized multiwall carbon nanotube nanocomposite coating on 316L stainless steel for biomedical application | |
| Wang et al. | Antimicrobial property, cytocompatibility and corrosion resistance of Zn-doped ZrO2/TiO2 coatings on Ti6Al4V implants | |
| US5454886A (en) | Process of activating anti-microbial materials | |
| US5681575A (en) | Anti-microbial coating for medical devices | |
| Di et al. | Ag nanoparticles incorporated tannic acid/nanoapatite composite coating on Ti implant surfaces for enhancement of antibacterial and antioxidant properties | |
| CN101745147A (en) | Zinc oxide coating modified in vivo implanted artificial organ and preparation method thereof | |
| US5837275A (en) | Anti-microbial materials | |
| Xu et al. | Polydopamine coatings embedded with silver nanoparticles on nanostructured titania for long-lasting antibacterial effect | |
| Tang et al. | Superior antibacterial properties of copper-doped titanium oxide films prepared by micro-arc oxidation | |
| CN103834945B (en) | A kind of titanium oxide composite coating and preparation method thereof | |
| CN101869725B (en) | Antibacterial bioactivity composite coating comprising nano Ag particles and preparation method | |
| CN105862001A (en) | TiN-Ag nano composite coating and preparation and application thereof | |
| Xu et al. | Investigation of magnetron sputtered nano-silver coating on titanium surface with micro-nanostructure | |
| CN103920185A (en) | Mo metal doped composite diamond-like coating titanium alloy artificial bone joint and manufacturing method thereof | |
| Uhm et al. | Fabrication of bioactive, antibacterial TiO2 nanotube surfaces, coated with magnetron sputtered Ag nanostructures for dental applications | |
| Kaliaraj et al. | Studies of calcium-precipitating oral bacterial adhesion on TiN, TiO2 single layer, and TiN/TiO2 multilayer-coated 316L SS | |
| CN103046056B (en) | Method for preparing Ag-Ti-O antibacterial nanotube film on surface of titanium alloy | |
| CN105420680B (en) | A kind of preparation method of pure titanium surface A g/Sr codope TiO2 porous membranes | |
| CN107190234B (en) | A kind of TiN/Ag nano-multilayer film and the preparation method and application thereof of surface note silver | |
| CN107447197A (en) | Biological TiN Ag nano composite multiple layers film and application prepared by magnetic control More target sputtering together technology | |
| CN103911593B (en) | A kind of titanium alloy surface Ag doped Ti O 2the preparation method of film | |
| CN107583107B (en) | Tantalum boride biological coating and preparation method and application thereof | |
| CN116288203B (en) | Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof | |
| CN113018510B (en) | Method for modifying surface of titanium-based implant and composite coating on surface of titanium-based implant | |
| CN109652766B (en) | Magnesium-silver-copper coating for medical implant material and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |